Adcock Ingram Breaks Into Biosimilars With Infliximab

As Pandemic Disrupts Annual Prescription Sales

 
• By Dean Rudge
  
running athletic race track with blending South Africa flag
Adcock Ingram has debuted its first biosimilar product • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products